
David J. Margolis, MD, Ph.D
Gerald R. Lazarus Professor
Department: Dermatology
Graduate Group Affiliations
Contact information
727 South Perelman Center for Advanced Medicine
3400 Civic Center BLVD
Department of Dermatology and Department of Biostatistics and Epidemiology
University of Pennsylvania
Philadelphia, PA 19104-4283
3400 Civic Center BLVD
Department of Dermatology and Department of Biostatistics and Epidemiology
University of Pennsylvania
Philadelphia, PA 19104-4283
Office: 215-662-2590
Lab: 215-898-4938
Lab: 215-898-4938
Publications
Education:
B.A.
Wesleyan University, 1981.
M.D.
University of Chicago-Pritzker, 1985.
M.S.C.E. (Epidemiology)
University of Pennsylvania, 1998.
Ph.D. (Epidemiology)
University of Pennsylvania, 2000.
Permanent linkB.A.
Wesleyan University, 1981.
M.D.
University of Chicago-Pritzker, 1985.
M.S.C.E. (Epidemiology)
University of Pennsylvania, 1998.
Ph.D. (Epidemiology)
University of Pennsylvania, 2000.
Description of CCEB Expertise
Dr. Margolis's research work is focused on DermatoEpidemiology and more specifically the epidemiology and treatment of chronic wounds. It is important to realize that more than 7 million Americans suffer from these wounds and the US spends more than $10 billion per year caring for individuals with these medical problems. He has been and is currently the Principal Investigator of several grants from NIH, FDA, AHRQ, industry, and foundations. These studies focus on chronic wounds (such as diabetic foot ulcers and venous leg ulcers). His contributions are important to our current understanding and practice regarding the design, choice of surrogate endpoints, and statistical analysis plan of studies addressing wound repair. The clinical assessments he innovated are now routinely incorporated into clinical trials designed to explore new treatments of venous legs and diabetic foot ulcers. Additional evidence of their importance is their incorporation into clinical treatment and evaluation guidelines used by insurers. He also has studies on the genetics of Atopic Dermatology, severe cutaneous drug eruptions, antibiotic use in acne, and the safety of therapy for dermatologic illnesses. His work focuses on epidemiologic study designs, comparative effectiveness designs and clinical trials. He is the founding director of the Center for DermatoEpidemilogy and Translation of the Perelman School of Medicine. He has published more than 175 scientific papers and frequently lectures at national and international meetings.Description of Content-based Expertise
Aging, Cancer Epidemiology, Infectious Diseases, Patient-Oriented Research, Pharmacoepidemiology, DermatologyDescription of Methodology Expertise
Categorical Data, Clinical Trials, Diagnostic Testing, Meta-analysisSelected Publications
Palepu S, Sindgi VM, Aylur KS, Margolis DJ, Kovarik C.: Mental Health and Substance Use Amongst Trans Women in India. J Homosex Mar 2025.Grice EA, Brennan-Crispi D, Rodriguez N, Margolis DJ, Seykora JT, Cotsarelis G, Taylor SC, Shuda J.: Penn Academy for Skin Health (PASH): An Experiential Pipeline Program in Skin Biology and Dermatology for High-School Students. J Invest Dermatol 145(3): 478-480, Mar 2025.
Bibineyshvili Y, Vajtay TJ, Salsabilian S, Fliss N, Suvarnakar A, Fang J, Teng S, Alder J, Najafizadeh L, Margolis DJ.: Imaging the large-scale and cellular response to focal traumatic brain injury in mouse neocortex. Exp Physiol 110(2): 321-344, Feb 2025.
Barbieri JS, Ellenberg S, Grice E, Tierney A, VanderBeek SB, Papadopoulos M, Mason J, Mason A, Dattilo J, Margolis DJ.: Challenges in designing a randomized, double-blind noninferiority trial for treatment of acne: The SD-ACNE trial. Clin Trials 22(1): 66-76, Feb 2025.
Lydecker AD, Kim JJ, Robinson GL, Johnson JK, Brown CH, Petruccelli CC, Terrin ML, Margolis DJ, Roghmann MC.: Chlorhexidine vs Routine Foot Washing to Prevent Diabetic Foot Ulcers: A Randomized Clinical Trial. JAMA Netw Open 8(2): e2460087, Feb 2025.
Nouri Z, Biglari S, Tabatabaiefar MA, Vahidnezhad F, Hozhabrpour A, March ME, Margolis DJ, Gudjonsson JE, Hakonarson H, Vahidnezhad H.: Filaggrinopathies-FLG/FLG2: Diagnostic Complexities and Immunotherapy. J Invest Dermatol(24), Feb 2025.
Barbieri JS, Ellenberg SS, Tierney A, VanderBeek SB, Papadopoulos M, Mason J, Mason A, Dattilo J, Margolis DJ.: Establishing minimally important difference thresholds for lesion counts in acne clinical studies. J Am Acad Dermatol(25), Jan 2025.
Wong JJ, Margolis DJ.: Association Between Food Allergy Status and Atopic Dermatitis Control and Persistence: A Longitudinal Analysis of the Pediatric Eczema Elective Registry. Pediatr Dermatol Dec 2024.
Chiesa Fuxench ZC, Mitra N, Grice E, Hoffstad O, Margolis DJ.: Is seborrhoeic dermatitis of infancy and childhood related to maternal history of seborrhoeic dermatitis? A large population-based cohort study from the UK. Br J Dermatol 192(1): 72-77, Dec 2024.
Rosenthal BE, Schaubel DE, Lewis JD, Margolis DJ, Goldberg DS, Bittermann T.: Immunosuppression regimen and latitude impact keratinocyte carcinoma risk in U.S. liver transplant recipients. Arch Dermatol Res 316(9): 641, Sep 2024.